417 related articles for article (PubMed ID: 31964157)
1. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
Wang N; Feng Y; Tan HY; Cheung F; Hong M; Lao L; Nagamatsu T
J Ethnopharmacol; 2015 Apr; 164():309-18. PubMed ID: 25700642
[TBL] [Abstract][Full Text] [Related]
3. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
Li M; Shang H; Wang T; Yang SQ; Li L
World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.
Yin B; Bi YM; Fan GJ; Xia YQ
J Diabetes Res; 2020; 2020():5273914. PubMed ID: 33134394
[TBL] [Abstract][Full Text] [Related]
5. Systems pharmacology, proteomics and in vivo studies identification of mechanisms of cerebral ischemia injury amelioration by Huanglian Jiedu Decoction.
Shang J; Li Q; Jiang T; Bi L; Lu Y; Jiao J; Song Q; Yan M; Shabuerjiang L; Wang J; Liu X
J Ethnopharmacol; 2022 Jul; 293():115244. PubMed ID: 35378193
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction.
He MY; Deng YX; Shi QZ; Zhang XJ; Lv Y
J Ethnopharmacol; 2014 Aug; 155(1):334-42. PubMed ID: 24910405
[TBL] [Abstract][Full Text] [Related]
7. Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Huanglian Jiedu Decoction in Treating Atherosclerosis.
Liang J; Huang Y; Mai Z; Zhan Q; Lin H; Xie Y; Wang H; Liu Y; Luo C
Drug Des Devel Ther; 2021; 15():1779-1795. PubMed ID: 33958856
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome
Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P
Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506
[TBL] [Abstract][Full Text] [Related]
9. Effects of the modified Huanglian Jiedu decoction on the disease resistance in grey mullet (Mugil cephalus) to Lactococcus garvieae.
Choi WM; Lam CL; Mo WY; Cheng Z; Mak NK; Bian ZX; Wong MH
Mar Pollut Bull; 2014 Aug; 85(2):816-23. PubMed ID: 24846297
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis.
Li X; Wei S; Niu S; Ma X; Li H; Jing M; Zhao Y
Comput Biol Med; 2022 May; 144():105389. PubMed ID: 35303581
[TBL] [Abstract][Full Text] [Related]
11. Integrating Network Pharmacology and Experimental Models to Investigate the Mechanism of Huanglian Jiedu Decoction on Inflammatory Injury Induced by Cerebral Ischemia.
Li H; Lv T; Wang B; Li M; Liu J; Wang C; Tang Z
Evid Based Complement Alternat Med; 2021; 2021():2135394. PubMed ID: 33519941
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
13. Huanglian Jiedu decoction inhibits vascular smooth muscle cell-derived foam cell formation by activating autophagy via suppressing P2RY12.
Lin J; Gu M; Wang X; Chen Y; Chau NV; Li J; Chu Q; Qing L; Wu W
J Ethnopharmacol; 2024 Jun; 328():118125. PubMed ID: 38561055
[TBL] [Abstract][Full Text] [Related]
14. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract][Full Text] [Related]
15. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
[TBL] [Abstract][Full Text] [Related]
16. Exploring the mechanisms underlying the therapeutic effect of the
Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
18. Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology.
Gong Z; Li R; Chen S; Wu H; Cai Y; Li J; Zhao X; Chu Q; Luo C; Qing L; Li N; Wu W
J Healthc Eng; 2022; 2022():2457706. PubMed ID: 36061816
[TBL] [Abstract][Full Text] [Related]
19. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.
Yang J; Tang C; Jin R; Liu B; Wang P; Chen Y; Zeng C
Sci Rep; 2022 Apr; 12(1):5526. PubMed ID: 35365737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
